MARKERS OF SYSTEMIC INFLAMMATION AND MATRIX METALLOPROTEINASE / TISSUE INHIBITOR OF METALLOPROTEINASES SYSTEM AT DIFFERENT STAGES OF CHRONIC HEART FAILURE

Código QR

MARKERS OF SYSTEMIC INFLAMMATION AND MATRIX METALLOPROTEINASE / TISSUE INHIBITOR OF METALLOPROTEINASES SYSTEM AT DIFFERENT STAGES OF CHRONIC HEART FAILURE

Abstract. A comparative analysis of endotoxinemia grade, tumor necrosis factor α, C-reactive protein, sEselectin, matrix metalloproteinase-9 (MMP) and tissue inhibitor of metalloproteinases-4 (TIMP) levels was performed in a group of patients with chronic heart failure (CHF). An association has been...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	E. N. Egorova, M. A. Kuzmina, V. V. Masur, M. N. Kalinkin, E. S. Mazur
Formato:	article
Lenguaje:	RU
Publicado:	SPb RAACI 2014
Materias:	chronic heart failure pathogenesis chronic systemic inflammation endotoxin proinflammatory cytokines matrix metalloproteinases Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/77c253dfa7cb4d95a71c6bc9aba39971
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF MATRIX METALLOPROTEINASES DURING PREGNANCY AND DELIVERY
por: Yu. V. Korenovsky, et al.
Publicado: (2012)

The role of matrix metalloproteinases in the myocardial remodeling
por: Vladlen V. Bazylev, et al.
Publicado: (2020)

Dynamics of Matrix Metalloproteinases in Local Cold Injury
por: M. I. Mikhailichenko, et al.
Publicado: (2019)

Peculiarities of synthesis of matrix metalloproteinase-9 in the lungs during experimental development of distress syndrome
por: E. V. Prutkina, et al.
Publicado: (2013)

The Role of Matrix Metalloproteinases in Endometriosis: A Potential Target
por: Junya Ke, et al.
Publicado: (2021)

Relationships between Circulating Matrix Metalloproteinases, Tissue Inhibitor TIMP-2, and Renal Function in Patients with Myocarditis
por: Małgorzata Kobusiak-Prokopowicz, et al.
Publicado: (2021)

Effect of prostaglandin analogs on matrix metalloproteinases and tissue inhibitor of metalloproteinases in eyelid muscle specimens
por: Karli S, et al.
Publicado: (2018)

EXTRACELLULAR MATRIX CONDITION IN CASE OF HCVASSOCIATED LIVER FIBROSIS
por: I. S. Gorelova, et al.
Publicado: (2017)

Administration of ghrelin associated with decreased expression of matrix metalloproteinase-9 following normobaric systemic hypoxia in the brain
por: Mohaddes Gisou, et al.
Publicado: (2018)

Insights Into the Regulation of Gynecological Inflammation-Mediated Malignancy by Metalloproteinases
por: Yasmin Begum, et al.
Publicado: (2021)

Orosomucoid 1 promotes epirubicin resistance in breast cancer by upregulating the expression of matrix metalloproteinases 2 and 9
por: Luo Qiong, et al.
Publicado: (2021)

Histopathologic Findings Associated With Matrix Metalloproteinases Proceeding to Recurrence of Primary Spontaneous Pneumothorax in Adolescents
por: Chih-Yung Chiu, et al.
Publicado: (2021)

Clinical significance of matrix metalloproteinase (MMP)-2 and MMP-9 expression in laryngeal squamous cell carcinoma
por: Rašić Dejan, et al.
Publicado: (2021)

Dentine matrix metalloproteinases as potential mediators of dentine regeneration
por: E Guirado, et al.
Publicado: (2021)

Proteoform Analysis of Matrix Metalloproteinase-9/Gelatinase B and Discovery of Its Citrullination in Rheumatoid Arthritis Synovial Fluids
por: Bernard Grillet, et al.
Publicado: (2021)

Matrix metalloproteinase 2/9-triggered-release micelles for inhaled drug delivery to treat lung cancer: preparation and in vitro/in vivo studies
por: Wang X, et al.
Publicado: (2018)

The contribution of chronic endometritis to reproductive system disorders in patients with repeated implantation failures
por: Victor E. Radzinsky, et al.
Publicado: (2021)

Diagnostic Value of Serum and Saliva Matrix Metalloproteinase13 (MMP13) in Oral Squamous Cell Carcinoma
por: T Ghanbarnia, et al.
Publicado: (2020)

Unifloral ajwain honey ameliorates differential inhibition of matrix metalloproteinases 2 and 9 protein, cytotoxicity, and antioxidant potential
por: Shruti S. Kulkarni, et al.
Publicado: (2021)

Matrix Metalloproteinases Inhibition by Doxycycline Rescues Extracellular Matrix Organization and Partly Reverts Myofibroblast Differentiation in Hypermobile Ehlers-Danlos Syndrome Dermal Fibroblasts: A Potential Therapeutic Target?
por: Nicola Chiarelli, et al.
Publicado: (2021)

Vimentin Expression in Nasal Mucosa of Patients with Exacerbated Chronic Rhinosinusitis Without Nasal Polyps
por: Onishchenko A. I., et al.
Publicado: (2019)

EXPRESSION OF MATRIX METALLOPROTEINASES IN LACRIMAL FLUID AND GENE POLYMORPHISM OF COMPLEMENT FACTOR H (CFH) IN PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA
por: V. A. Sokolov, et al.
Publicado: (2017)

Production of factors involved into fibrosis regulation by various types of human macrophages
por: A. A. Maksimova, et al.
Publicado: (2020)

Evolución del compromiso cardiovascular de pacientes insuficientes renales, en hemodiálisis, sin bloqueo del eje renina-angiotensina
por: Kunstmann,Sonia, et al.
Publicado: (2009)

Matrix metalloproteinases-2/9-sensitive peptide-conjugated polymer micelles for site-specific release of drugs and enhancing tumor accumulation: preparation and in vitro and in vivo evaluation
por: Zhang X, et al.
Publicado: (2016)

Matrix Metalloproteinases in Relation to Bone Mineral Density: A Two-Sample Mendelian Randomization Study
por: Xin Lv, et al.
Publicado: (2021)

Protective effects on myocardial infarction model: delivery of schisandrin B using matrix metalloproteinase-sensitive peptide-modified, PEGylated lipid nanoparticles
por: Shao M, et al.
Publicado: (2017)

Remote Hind-Limb Ischemia Mechanism of Preserved Ejection Fraction During Heart Failure
por: Rubens P. Homme, et al.
Publicado: (2021)

Effects of growth factors and cytokins on soft tissue regeneration in patients with diabetes mellitus
por: Ekaterina Leonidovna Zaytseva, et al.
Publicado: (2014)

Anemia from the perspective of the problem of chronic heart failure: pathogenesis and laboratory diagnosis
por: V.P. Ivanov, et al.
Publicado: (2018)

ASSOCIATION OF MATRIX METALLOPROTEINASES GENE POLYMORPHISM WITH CLINICAL MANIFESTATIONS OF BRONCHIAL ASTHMA IN CHILDREN
por: A. A. Lebedenko, et al.
Publicado: (2018)

Effect of Tranexamic Acid on Migration Ability and Level of Matrix Metalloproteinases-2 and -9 of T98G and HUVEC Cells in Co-Culture Conditions
por: H Esmaeili, et al.
Publicado: (2020)

Polymorphism of vascular endothelial growth factor gene (<i>VEGF</i>) and matrix metalloproteinase (<i>ММР</i>) genes in primary limb lymphedema
por: A. V. Shevchenko, et al.
Publicado: (2020)

Research progress on the application of traditional Chinese medicine in the draining water method of chronic heart failure
por: Rui Huang, et al.
Publicado: (2021)

Content of cytokine inflammatory markers in patients with chronic heart failure caused by cardiomyopathy
por: K. A. Khamitova, et al.
Publicado: (2017)

Association of polymorphism -1171 5A/6A of the matrix metalloproteinase gene type 3 (rs35068180) with dilated cardiomyopathy
por: Oxana O. Kuznetsova, et al.
Publicado: (2020)

Sesquiterpenes From Oplopanax elatus Stems and Their Anti-Photoaging Effects by Down-Regulating Matrix Metalloproteinase-1 Expression via Anti-Inflammation
por: Jiejing Yan, et al.
Publicado: (2021)

Circular RNA hsa_circ_0002360 promotes non-small cell lung cancer progression through upregulating matrix metalloproteinase 16 and sponging multiple micorRNAs
por: Yunting Zhang, et al.
Publicado: (2021)

Metalloproteinases in Inflammatory Bowel Diseases
por: Marônek M, et al.
Publicado: (2021)

Matrix metalloproteinase-9 and p53 involved in chronic fluorosis induced blood-brain barrier damage and neurocyte changes
por: Shen Qing-Feng, et al.
Publicado: (2019)